Case report: A fatal outcome from co-infection of COVID-19 and dengue in the western region of Jeddah, Saudi Arabia.
| Autor: | Al-Nazawi AM; Preventive Medicine Department, Public Health Directorate, Ministry of Health, Jeddah, Saudi Arabia., Al-Zahrani AA; Preventive Medicine Department, Public Health Directorate, Ministry of Health, Jeddah, Saudi Arabia., Qadir A; Health Holding Company, Jeddah, Saudi Arabia., Alghamdi R; Preventive Medicine Department, Public Health Directorate, Ministry of Health, Jeddah, Saudi Arabia., Tambo E; Faculty of Health Sciences, Sydney Brenner Institute for Molecular Bioscience, Wits 21st Century Institute, University of the Witwatersrand, Johannesburg, South Africa., Alsahafi A; Preventive Medicine Department, Public Health Directorate, Ministry of Health, Jeddah, Saudi Arabia. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Frontiers in public health [Front Public Health] 2022 Aug 16; Vol. 10, pp. 942381. Date of Electronic Publication: 2022 Aug 16 (Print Publication: 2022). |
| DOI: | 10.3389/fpubh.2022.942381 |
| Abstrakt: | Introduction: Co-infection of coronavirus disease 2019 (COVID-19) and dengue may coexist, as both viruses share similar laboratory and clinical features, making diagnosis and treatment challenging for health care professionals to prescribe, negatively impacting patient prognosis, and outcomes. Results and Discussions: Both cases were positive for PCR and X-ray laboratory investigation at clinical examination, confirming COVID-19 and dengue co-infection, admission, and better management in referral hospitals are presented and discussed. The timeline provides detailed cases of situational analysis and the medical actions taken, as well as the outcomes. Conclusion: Both co-infection cases' (patients) health conditions had a poor prognosis and diagnosis and ended with undesired outcomes. Scaling up dual mosquito-vector linked viral diseases surveillance in understanding the transmission dynamics, early diagnosis, and the timely and safe monitoring of case management in clinical and hospital settings nationwide is paramount in curbing preventable co-infections and mortality. Competing Interests: AQ was employed by Health Holding Company. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2022 Al-Nazawi, Al-Zahrani, Qadir, Alghamdi, Tambo and Alsahafi.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|